Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters











Database
Language
Publication year range
1.
PLoS One ; 10(6): e0129402, 2015.
Article in English | MEDLINE | ID: mdl-26047317

ABSTRACT

Ablation of glycosylated lysosomal membrane protein (GLMP, formerly known as NCU-G1) has been shown to cause chronic liver injury which progresses into liver fibrosis in mice. Both lysosomal dysfunction and chronic liver injury can cause metabolic dysregulation. Glmp gt/gt mice (formerly known as Ncu-g1gt/gt mice) were studied between 3 weeks and 9 months of age. Body weight gain and feed efficiency of Glmp gt/gt mice were comparable to wild type siblings, only at the age of 9 months the Glmp gt/gt siblings had significantly reduced body weight. Reduced size of epididymal fat pads was accompanied by hepatosplenomegaly in Glmp gt/gt mice. Blood analysis revealed reduced levels of blood glucose, circulating triacylglycerol and non-esterified fatty acids in Glmp gt/gt mice. Increased flux of glucose, increased de novo lipogenesis and lipid accumulation were detected in Glmp gt/gt primary hepatocytes, as well as elevated triacylglycerol levels in Glmp gt/gt liver homogenates, compared to hepatocytes and liver from wild type mice. Gene expression analysis showed an increased expression of genes involved in fatty acid uptake and lipogenesis in Glmp gt/gt liver compared to wild type. Our findings are in agreement with the metabolic alterations observed in other mouse models lacking lysosomal proteins, and with alterations characteristic for advanced chronic liver injury.


Subject(s)
Lipogenesis/genetics , Liver/metabolism , Lysosomes/metabolism , Membrane Proteins/genetics , Adipose Tissue/metabolism , Animals , Blood Glucose/metabolism , Blotting, Western , Cells, Cultured , Epididymis/metabolism , Fatty Acids/blood , Gene Expression , Glucose Transporter Type 2/genetics , Glucose Transporter Type 2/metabolism , Hepatocytes/metabolism , Hepatomegaly/blood , Hepatomegaly/genetics , Lipid Metabolism/genetics , Liver/pathology , Male , Membrane Proteins/metabolism , Mice, Knockout , Protein Serine-Threonine Kinases/genetics , Protein Serine-Threonine Kinases/metabolism , Pyruvate Dehydrogenase Acetyl-Transferring Kinase , Reverse Transcriptase Polymerase Chain Reaction , Splenomegaly/blood , Splenomegaly/genetics , Triglycerides/blood , Weight Gain/genetics
2.
J Biol Chem ; 290(22): 14166-80, 2015 May 29.
Article in English | MEDLINE | ID: mdl-25903133

ABSTRACT

The vacuolar H(+)-ATPase (v-ATPase) complex is instrumental in establishing and maintaining acidification of some cellular compartments, thereby ensuring their functionality. Recently it has been proposed that the transmembrane V0 sector of v-ATPase and its a-subunits promote membrane fusion in the endocytic and exocytic pathways independent of their acidification functions. Here, we tested if such a proton-pumping independent role of v-ATPase also applies to phagosome-lysosome fusion. Surprisingly, endo(lyso)somes in mouse embryonic fibroblasts lacking the V0 a3 subunit of the v-ATPase acidified normally, and endosome and lysosome marker proteins were recruited to phagosomes with similar kinetics in the presence or absence of the a3 subunit. Further experiments used macrophages with a knockdown of v-ATPase accessory protein 2 (ATP6AP2) expression, resulting in a strongly reduced level of the V0 sector of the v-ATPase. However, acidification appeared undisturbed, and fusion between latex bead-containing phagosomes and lysosomes, as analyzed by electron microscopy, was even slightly enhanced, as was killing of non-pathogenic bacteria by V0 mutant macrophages. Pharmacologically neutralized lysosome pH did not affect maturation of phagosomes in mouse embryonic cells or macrophages. Finally, locking the two large parts of the v-ATPase complex together by the drug saliphenylhalamide A did not inhibit in vitro and in cellulo fusion of phagosomes with lysosomes. Hence, our data do not suggest a fusion-promoting role of the v-ATPase in the formation of phagolysosomes.


Subject(s)
Lysosomes/metabolism , Phagosomes/metabolism , Proton-Translocating ATPases/metabolism , Receptors, Cell Surface/metabolism , Vacuolar Proton-Translocating ATPases/metabolism , Animals , Escherichia coli/metabolism , Female , Fibroblasts/metabolism , Hydrogen-Ion Concentration , Macrophages/cytology , Macrophages/metabolism , Macrophages/microbiology , Male , Membrane Fusion , Mice , Mice, Knockout , Mice, Transgenic , Microscopy, Electron , Microscopy, Fluorescence , Subcellular Fractions/metabolism
3.
Dis Model Mech ; 7(3): 351-62, 2014 Mar.
Article in English | MEDLINE | ID: mdl-24487409

ABSTRACT

Human kidney predominant protein, NCU-G1, is a highly conserved protein with an unknown biological function. Initially described as a nuclear protein, it was later shown to be a bona fide lysosomal integral membrane protein. To gain insight into the physiological function of NCU-G1, mice with no detectable expression of this gene were created using a gene-trap strategy, and Ncu-g1(gt/gt) mice were successfully characterized. Lysosomal disorders are mainly caused by lack of or malfunctioning of proteins in the endosomal-lysosomal pathway. The clinical symptoms vary, but often include liver dysfunction. Persistent liver damage activates fibrogenesis and, if unremedied, eventually leads to liver fibrosis/cirrhosis and death. We demonstrate that the disruption of Ncu-g1 results in spontaneous liver fibrosis in mice as the predominant phenotype. Evidence for an increased rate of hepatic cell death, oxidative stress and active fibrogenesis were detected in Ncu-g1(gt/gt) liver. In addition to collagen deposition, microscopic examination of liver sections revealed accumulation of autofluorescent lipofuscin and iron in Ncu-g1(gt/gt) Kupffer cells. Because only a few transgenic mouse models have been identified with chronic liver injury and spontaneous liver fibrosis development, we propose that the Ncu-g1(gt/gt) mouse could be a valuable new tool in the development of novel treatments for the attenuation of fibrosis due to chronic liver damage.


Subject(s)
Iron/metabolism , Kupffer Cells/metabolism , Lipofuscin/metabolism , Liver Cirrhosis/metabolism , Lysosomes/metabolism , Membrane Proteins/metabolism , Animals , Cathepsin D/metabolism , Cell Death , Collagen/metabolism , Female , Fluorescence , Gene Targeting , Hepatocytes/metabolism , Hepatocytes/pathology , Humans , Inflammation/pathology , Kupffer Cells/pathology , Kupffer Cells/ultrastructure , Liver/metabolism , Liver/pathology , Liver Cirrhosis/pathology , Male , Mice, Inbred C57BL , Oxidative Stress , Phenotype , Reproducibility of Results , Splenomegaly/metabolism , Splenomegaly/pathology
SELECTION OF CITATIONS
SEARCH DETAIL